공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 다낭성난소증후군 치료제 시장 분석(2021년) : 코로나19(COVID-19)에 의한 성장과 변화(-2030년)

Polycystic Ovarian Syndrome Treatment Global Market Report 2021: COVID-19 Growth And Change To 2030

리서치사 The Business Research Company
발행일 On Demand Report 상품 코드 1028791
페이지 정보 영문 175 Pages
가격
US $ 5,000 ₩ 5,919,000 PDF (Single User License)
US $ 7,500 ₩ 8,878,000 PDF (Site License)
US $ 10,000 ₩ 11,838,000 PDF (Enterprise License)


세계의 다낭성난소증후군 치료제 시장 분석(2021년) : 코로나19(COVID-19)에 의한 성장과 변화(-2030년) Polycystic Ovarian Syndrome Treatment Global Market Report 2021: COVID-19 Growth And Change To 2030
발행일 : On Demand Report 페이지 정보 : 영문 175 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 다낭성난소증후군(Polycystic Ovarian Syndrome) 치료제 시장의 구조와 동향에 대해 분석했으며, 시장의 주요 특징과 구조, 전체적인 시장 규모·성장률 동향 전망, 약제 유형별·지역별·주요 국가별 상세 동향, 주요 기업 개요, 최근의 주요 동향, 향후 시장 기회 등에 대해 전해드립니다.

목차

제1장 개요

제2장 다낭성난소증후군 치료제 시장의 특징

제3장 다낭성난소증후군 치료제 시장 동향과 전략

제4장 다낭성난소증후군 치료제 시장에 대한 코로나19(COVID-19)의 영향

제5장 다낭성난소증후군 치료제 시장 : 시장 규모 및 성장률

  • 시장 규모(단위 : 10억 달러, 2015-2020년)
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
  • 시장 규모(단위 : 10억 달러, 2020-2025년, 2030년)
    • 시장 성장 촉진요인
    • 시장 성장 억제요인

제6장 다낭성난소증후군 치료제 시장 : 분야별 분석

  • 약제 유형별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)
  • 경구 피임약
  • 오르니틴 탈탄산효소 억제제
  • 인슐린 저항성 개선제
  • 항우울제
  • 이뇨제
  • 아로마타제 억제제
  • 수술 유형별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)
  • 난소 설상 절제술
  • 복강경하 난소 천공
  • 최종사용자별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)
  • 병원/클리닉
  • 외래수술센터
  • 진단 센터
  • 부인과 센터
  • 여성용 의료 센터

제7장 다낭성난소증후군 치료제 시장 : 지역별/국가별 분석

  • 지역별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)
  • 국가별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)

제8장 아시아태평양의 다낭성난소증후군 치료제 시장

  • 시장 개요
  • 지역 정보
  • 약제 유형별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽의 다낭성난소증후군 치료제 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 동유럽의 다낭성난소증후군 치료제 시장

제20장 러시아 시장

제21장 북미의 다낭성난소증후군 치료제 시장

제22장 미국 시장

제23장 남미의 다낭성난소증후군 치료제 시장

제24장 브라질 시장

제25장 중동의 다낭성난소증후군 치료제 시장

제26장 아프리카의 다낭성난소증후군 치료제 시장

제27장 다낭성난소증후군 치료제 시장 : 경쟁 구도와 기업 개요

  • 경쟁 구도
  • 기업 개요
    • Bristol-Myer Squibb Company
    • Bayer AG
    • Pfizer, Inc.
    • Merck KGaA
    • Sanofi

제28장 다낭성난소증후군 치료제 파이프라인 제품 분석

제29장 다낭성난소증후군 치료제 시장의 주요 인수합병(M&A)

제30장 다낭성난소증후군 치료제 시장 : 전망과 잠재력 분석

제31장 부록

LSH 21.09.30

“Polycystic Ovarian Syndrome Treatment Global Market Report 2021: COVID-19 Growth And Change to 2030” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global polycystic ovarian syndrome treatment market.

This report focuses on polycystic ovarian syndrome treatment market which is experiencing strong growth. The report gives a guide to the polycystic ovarian syndrome treatment market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the polycystic ovarian syndrome treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Polycystic Ovarian Syndrome Treatment market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider polycystic ovarian syndrome treatment market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The polycystic ovarian syndrome treatment market section of the report gives context. It compares the polycystic ovarian syndrome treatment market with other segments of the polycystic ovarian syndrome treatment market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, polycystic ovarian syndrome treatment indicators comparison.

Scope

Markets Covered:

1) By Drug Type: Oral Contraceptives; Ornithine Decarboxylase Inhibitors; Insulin-Sensitizing Agents; Anti-Depressants; Diuretics; Aromatase Inhibitors

2) By Surgery Type: Ovarian Wedge Resection; Laparoscopic Ovarian Drilling

3) By End User: Hospitals & Clinics; Ambulatory Surgical Centers; Diagnostic Centers; Gynecology Centers; Feminist Health Centers

Companies Mentioned: Bristol-Myer Squibb Company; Bayer AG; Pfizer, Inc.; Merck KGaA; Sanofi

Countries: Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, Australia

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Polycystic Ovarian Syndrome Treatment Market Characteristics

3. Polycystic Ovarian Syndrome Treatment Market Trends And Strategies

4. Impact Of COVID-19 On Polycystic Ovarian Syndrome Treatment

5. Polycystic Ovarian Syndrome Treatment Market Size And Growth

  • 5.1. Global Polycystic Ovarian Syndrome Treatment Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Polycystic Ovarian Syndrome Treatment Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Polycystic Ovarian Syndrome Treatment Market Segmentation

  • 6.1. Global Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Oral Contraceptives
  • Ornithine Decarboxylase Inhibitors
  • Insulin-Sensitizing Agents
  • Anti-Depressants
  • Diuretics
  • Aromatase Inhibitors
  • 6.2. Global Polycystic Ovarian Syndrome Treatment Market, Segmentation By Surgery Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Ovarian Wedge Resection
  • Laparoscopic Ovarian Drilling
  • 6.3. Global Polycystic Ovarian Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Gynecology Centers
  • Feminist Health Centers

7. Polycystic Ovarian Syndrome Treatment Market Regional And Country Analysis

  • 7.1. Global Polycystic Ovarian Syndrome Treatment Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Polycystic Ovarian Syndrome Treatment Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Polycystic Ovarian Syndrome Treatment Market

  • 8.1. Asia-Pacific Polycystic Ovarian Syndrome Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Polycystic Ovarian Syndrome Treatment Market

  • 9.1. China Polycystic Ovarian Syndrome Treatment Market Overview
  • 9.2. China Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Polycystic Ovarian Syndrome Treatment Market

  • 10.1. India Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Polycystic Ovarian Syndrome Treatment Market

  • 11.1. Japan Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Polycystic Ovarian Syndrome Treatment Market

  • 12.1. Australia Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Polycystic Ovarian Syndrome Treatment Market

  • 13.1. Indonesia Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Polycystic Ovarian Syndrome Treatment Market

  • 14.1. South Korea Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Polycystic Ovarian Syndrome Treatment Market

  • 15.1. Western Europe Polycystic Ovarian Syndrome Treatment Market Overview
  • 15.2. Western Europe Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Polycystic Ovarian Syndrome Treatment Market

  • 16.1. UK Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Polycystic Ovarian Syndrome Treatment Market

  • 17.1. Germany Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Polycystic Ovarian Syndrome Treatment Market

  • 18.3. France Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Polycystic Ovarian Syndrome Treatment Market

  • 19.1. Eastern Europe Polycystic Ovarian Syndrome Treatment Market Overview
  • 19.2. Eastern Europe Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Polycystic Ovarian Syndrome Treatment Market

  • 20.1. Russia Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Polycystic Ovarian Syndrome Treatment Market

  • 21.1. North America Polycystic Ovarian Syndrome Treatment Market Overview
  • 21.2. North America Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Polycystic Ovarian Syndrome Treatment Market

  • 22.1. USA Polycystic Ovarian Syndrome Treatment Market Overview
  • 22.2. USA Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Polycystic Ovarian Syndrome Treatment Market

  • 23.1. South America Polycystic Ovarian Syndrome Treatment Market Overview
  • 23.2. South America Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Polycystic Ovarian Syndrome Treatment Market

  • 24.1. Brazil Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Polycystic Ovarian Syndrome Treatment Market

  • 25.1. Middle East Polycystic Ovarian Syndrome Treatment Market Overview
  • 25.2. Middle East Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Polycystic Ovarian Syndrome Treatment Market

  • 26.1. Africa Polycystic Ovarian Syndrome Treatment Market Overview
  • 26.2. Africa Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Polycystic Ovarian Syndrome Treatment Market Competitive Landscape And Company Profiles

  • 27.1. Polycystic Ovarian Syndrome Treatment Market Competitive Landscape
  • 27.2. Polycystic Ovarian Syndrome Treatment Market Company Profiles
    • 27.2.1. Bristol-Myer Squibb Company
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Bayer AG
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Pfizer, Inc.
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Merck KGaA
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Sanofi
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Polycystic Ovarian Syndrome Treatment Pipeline Analysis

29. Key Mergers And Acquisitions In The Polycystic Ovarian Syndrome Treatment Market

30. Polycystic Ovarian Syndrome Treatment Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer
Back to Top
전화 문의
F A Q